Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Clinical trial NCT02581930 · COMPLETED

Trial details

NCT number: NCT02581930
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma Recurrent Cutaneous Melanoma Stage IV Cutaneous Melanoma AJCC v6 and v7

Start date: 2016-12-16
Primary completion: 2021-09-09
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.